Structure Therapeutics

📍 South San Francisco, United States🗓 Founded 2017👥 79 employees💰 Last funded 2019
Biotechnology Research🌐 structuretx.com
Website LinkedIn
Structure Therapeutics creates life-changing medicines for patients using advanced computational and structure-based technology. Our platform combines the latest advancements in computational chemistry, visualization of molecular interactions, and data integration to design orally available, superior medicines that overcome current limitations in biologic and peptide drugs. We are advancing our clinical-stage pipeline of differentiated, efficacious and safe treatments focused on chronic diseases with high unmet need, including cardiovascular, metabolic and pulmonary conditions. At Structure, our team’s deep experience with complex biological targets and mechanisms, structure-based drug design, and global drug discovery and development enables our bold vision: to design and develop world-class medicines with tremendous patient impact and broad commercial opportunity.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2017
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
China
1
United States
1
Frequently asked questions
Who invested in Structure Therapeutics?
Structure Therapeutics has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Structure Therapeutics last raise funding?
The most recent investment in Structure Therapeutics recorded on gritt.io was in 2019.
When was Structure Therapeutics founded?
Structure Therapeutics was founded in 2017.
What industry is Structure Therapeutics in?
Structure Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Structure Therapeutics based?
Structure Therapeutics is headquartered in South San Francisco, United States.